JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Network
05/05/2025 21 min
JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Listen "JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

More episodes of the podcast JAMA Network

JAMA Ophthalmology : Foundation Models vs Physicians in Ophthalmological Questions 13/11/2025
JAMA Otolaryngology–Head & Neck Surgery : Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation 13/11/2025
JAMA Dermatology : Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis 12/11/2025
JAMA Internal Medicine : Lifestyle Intervention for Sustained Remission of Metabolic Syndrome 09/11/2025
JAMA Oncology : Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality 30/10/2025
JAMA Ophthalmology : Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy 30/10/2025
JAMA Psychiatry : Serial Ketamine Infusions as an Adjunctive Therapy to Inpatient Care for Depression 22/10/2025
JAMA Surgery : 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions 22/10/2025
JAMA Ophthalmology : Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year 17/10/2025
JAMA Otolaryngology–Head & Neck Surgery : The JAMA Otolaryngology-Head & Neck Surgery Editorial Fellowship Experience 16/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA